The US Food and Drug Administration (FDA) on Tuesday finalized two guidances providing recommendation for diagnostics makers looking to submit Clinical Laboratories Improvement Amendments (CLIA) ...
UPPSALA, SWEDEN / ACCESSWIRE / October 19, 2022 / Biovica International (STO:BIOVIC-B)(STO:BIOVIC.B)(FRA:9II) Biovica today announces that the company has submitted its CLIA lab application, marking ...
Stockhead’s Tylah Tully looks at news from Lumos Diagnostics (ASX:LDX), who has submitted its application to the FDA for CLIA waiver approval for FebriDx, a rapid point-of-care diagnostic test to ...
The US Food and Drug Administration (FDA) on Tuesday issued two draft guidances aimed at updating its recommendations for in vitro diagnostics (IVDs) seeking a waiver from requirements under the ...